Triad Wealth Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Triad Wealth Partners's AMGN Position: Q2 2026 in Review
Triad Wealth Partners increased its Amgen (AMGN) stake by 54% in Q2 2026, buying an estimated $259K and bringing the position to 2,169 shares worth $822K. The position accounts for 0.05% of the portfolio, ranked #228.
Triad Wealth Partners first reported a position in AMGN in Q2 2024 and has held it in 6 quarters since. 3,157 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Triad Wealth Partners held 2,169 shares of Amgen worth $822K as of Q2 2026.
- Triad Wealth Partners bought 756 Amgen shares in Q2 2026, an estimated $259K.
- Amgen made up 0.05% of Triad Wealth Partners's portfolio in Q2 2026, its #228 holding.
- Triad Wealth Partners first reported a position in Amgen in Q2 2024 and has held it in 6 quarters since.
- 3,157 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Triad Wealth Partners's 13F filing for Q2 2026, filed 10 Aug 2026.